Digital medical services platform Teladoc Health (NYSE:TDOC) will be reporting earnings tomorrow after the bell. Here's what investors should know.
Last quarter Teladoc reported revenues of $660.2 million, up 8% year on year, missing analyst expectations by 0.4%. It was a weak quarter for the company, with underwhelming revenue guidance for the next quarter. The company reported 90.2 million users, up 9.9% year on year.
Is Teladoc buy or sell heading into the earnings? Read our full analysis here, it's free.
This quarter analysts are expecting Teladoc's revenue to grow 5.2% year on year to $671.1 million, slowing down from the 15.1% year-over-year increase in revenue the company had recorded in the same quarter last year. Adjusted loss is expected to come in at -$0.24 per share.
Majority of analysts covering the company have reconfirmed their estimates over the last thirty days, suggesting they are expecting the business to stay the course heading into the earnings. The company missed Wall St's revenue estimates twice over the last two years.
Looking at Teladoc's peers in the consumer internet segment, some of them have already reported Q4 earnings results, giving us a hint of what we can expect. Pinterest reported revenues up 11.9% year on year, missing analyst estimates by 0.9%. Pinterest was down 9.5% on the results.
Read our full analysis of Pinterest's results here.
There has been positive sentiment among investors in the consumer internet segment, with the stocks up on average 4.1% over the last month. Teladoc is up 0.4% during the same time, and is heading into the earnings with analyst price target of $23, compared to share price of $21.0.
When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.